Complexity of Transcriptional and Translational Interference of Laminin-332 Subunits in Junctional Epidermolysis Bullosa with LAMB3 Mutations
DOI:
https://doi.org/10.2340/00015555-3874Keywords:
LAMB3, laminin-332, Junctional epidermolysis bullosaAbstract
Abstract is missing (Short communication)
Downloads
References
Bardhan A, Bruckner-Tuderman L, Chapple ILC, Fine JD, Harper N, Has C, et al. Epidermolysis bullosa. Nat Rev Dis Primers 2020; 6: 78.
Kiritsi D, Has C, Bruckner-Tuderman L. Laminin 332 in junctional epidermolysis bullosa. Cell Adh Migr 2013; 7: 135–141.
Chen F, Huang L, Li C, Zhang J, Yang W, Zhang B, et al. Next-generation sequencing through multigene panel testing for the diagnosis of hereditary epidermolysis bullosa in Chinese population. Clin Genet 2020; 98: 179–184.
Taggart JC, Zauber H, Selbach M, Li GW, McShane E. Keeping the proportions of protein complex components in check. Cell Syst 2020; 10: 125–132.
Matsui C, Pereira P, Wang CK, Nelson CF, Kutzkey T, Lanigan C, et al. Extent of laminin-5 assembly and secretion effect junctional epidermolysis bullosa phenotype. J Exp Med 1998; 187: 1273–1283.
Kwong A, Cogan J, Hou Y, Antaya R, Hao M, Kim G, et al. Gentamicin induces laminin-332 and improves wound healing in junctional epidermolysis bullosa patients with nonsense mutations. Mol Ther 2020; 28: 1327–1338.
Bidou L, Allamand V, Rousset JP, Namy O. Sense from nonsense: therapies for premature stop codon diseases. Trends Mol Med 2012; 18: 679–688.
Paez MC, Gonzalez MJ, Serrano NC, Shoenfeld Y, Anaya JM. Physiological and pathological implications of laminins: from the gene to the protein. Autoimmunity 2007; 40: 83–94.
Aumailley M, Rousselle P. Laminins of the dermo-epidermal junction. Matrix Biol 1999; 18: 19–28.
Sigle RO, Gil SG, Bhattacharya M, Ryan MC, Yang TM, Brown TA, et al. Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5. J Cell Sci 2004; 117: 4481–4494.
Meneguzzi G, Marinkovich MP, Aberdam D, Pisani A, Burgeson R, Ortonne JP. Kalinin is abnormally expressed in epithelial basement membranes of Herlitz’s junctional epidermolysis bullosa patients. Exp Dermatol 1992; 1: 221–229.
McGrath JA, Eady RA. The role of immunohistochemistry in the diagnosis of the non-lethal forms of junctional epidermolysis bullosa. J Dermatol Sci 1997; 14: 68–75.
McMillan JR, McGrath JA, Pulkkinen L, Kon A, Burgeson RE, Ortonne JP, et al. Immunohistochemical analysis of the skin in junctional epidermolysis bullosa using laminin 5 chain specific antibodies is of limited value in predicting the underlying gene mutation. Br J Dermatol 1997; 136: 817–822.
Ferrer-Cortès X, Narbona J, Bujan N, Matalonga L, Toro MD, Arranz JA, et al. A leaky splicing mutation in NFU1 is associated with a particular biochemical phenotype. Consequences for the diagnosis. Mitochondrion 2016; 26: 72–80.
Rousselle P, Beck K. Laminin-332 processing impacts cellular behavior. Cell Adh Migr 2013; 7: 122–134.
Additional Files
Published
How to Cite
Issue
Section
Categories
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
